您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [招银国际]:收益恢复可能在2026年第一季度亏损之后需要时间。 - 发现报告

收益恢复可能在2026年第一季度亏损之后需要时间。

2026-05-29 Ji SHI,Wenjing Do,Austin Liang 招银国际 🌱
报告封面

Earnings recovery may take time after 1Q26loss Maintain HOLD.Li Autorecorded the largest quarterly net loss since its 2020IPO. We expect net loss to extend into 2Q26E. While we still believe it is anoutstanding company,we are of the view thatLi Auto’sadvantageover peershas been narrowingbeforephysical AI become pivotalin the future.We cut ourFY26-27E net profit forecasts,which make its valuation unattractive(now 1Q26 revenue, GPM in line; strict SG&A control.Li Auto’s 1Q26revenue declined 11% YoY to RMB23.0bn,landing preciselyin line withour prior forecast. GPM narrowed by 10pptsQoQto 7.9% in 1Q26,or0.4ppts higher than our projection.SG&A expenses were aboutRMB650mn lower than our forecast, resulting in anarrower-than-expectednet loss of RMB2.3bn.Despite its cost control beat, the result still marks China Auto Portfolio maturity and mix shifts limit Li Auto’s near-term upside.Wemaintain our FY26E sales volume forecast of 0.49mn units, albeit with aworse model mix—we have raised sales volumeassumptionfor the low-margini6andtrimmedour outlookfor thepremiumL9. Managementhas guided a monthly sales volume of 6,000-8,000 units for the redesignedL9after ramping up amid heightened competition. More importantly, wesee GPMpressurecould bemore prolonged thanpreviouslyanticipated. Management has guided a vehicle GPM of about 10% for 2Q26, as thei6’sGPM is stilllowat asingle digit. We cut our FY26 GPM forecast from 17.6%to 15.0%—a trajectory that still optimistically requires 4Q26 recovery to 18-19%. More structurally, despite its premiumization efforts, Li Auto is now ina more difficult position to differentiate its products from competitors. Earnings/Valuation.With key assumptions outlined above, we cut ourFY26E net profit forecast by 85% to RMB511mn and FY27E net profit by21% to RMB6.1bn.We maintain our HOLDratings for ADS/H-share andtrim target prices from US$18.00/HK$70.00 to US$16.00/HK$62.00, whichis based on18x(prior 17x) our FY27E P/E. Key risks to our ratings and Source: FactSet Disclosures& Disclaimers Analyst Certification The research analyst who is primary responsible for thecontent of this research report, in whole or in part, certifies that with respect to the securities or issuerthat the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about the subject securitiesor issuer; and (2)no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific views expressed by that analyst in this report. Commission) (1) have dealt in or traded in the stock(s) covered in this research report within 30 calendar days prior to thedate of issue of this report; (2) willdeal in or trade in the stock(s) covered in this research report 3 business days after the date of issue of this report; (3) serve as an officer of any of the HongKong listed companies covered in this report; and (4) have any financial interests in the Hong Kong listedcompanies covered in this report. CMBIGM Ratings BUY: Stock with potential return of over 15% over next 12 monthsHOLD: Stock with potential return of +15% to-10% over next 12 monthsSELL: Stock with potential loss of over 10% over next 12monthsNOT RATED: Stock is not rated byCMBIGM ImportantDisclosures There are risks involved in transacting in any securities. The information contained in this report may not be suitable forthe purposes of all investors.CMBIGMdoes not provide individually tailored investment advice. This report has been prepared without regard to the individual investment objectives, financial positionor special requirements. Past performance has no indication of future performance, and actual events may differ materially from that which is contained in thereport.Thevalue of, and returns from, any investments are uncertain and are not guaranteed and may fluctuate as a result of their dependence on the or its affiliate(s) to whom it is distributed. This report is not and should not be construed as an offer or solicitation tobuy or sell any security or any interest insecuritiesor enter into any transaction.NeitherCMBIGMnor any of its affiliates, shareholders, agents, consultants, directors, officers or employees shall beliable for any loss, damage or expense whatsoever, whether direct or consequential, incurred in relying on the information contained in this report.Anyone CMBIGMhas exerted every effort in its capacity to ensure, but not to guarantee, their accuracy, completeness, timeliness or correctness.CMBIGMprovidesthe information, advices and forecasts on an "AS IS"basis.The information and contents are subject to change without notice.CMBIGMmay issue otherpublications having information and/ or conclusions different from this report.These publications reflect different assumption, point-of-view and analyticalmethods when compiling.CMBIGMmay make investment decisions or take proprietary positions that are inconsistent with the recommendations or views in C